Form 4 Filing for Brian Mueller - BIOMARIN PHARMACEUTICAL INC

This filing details stock transactions by Brian Mueller, EVP, Chief Financial Officer of BIOMARIN PHARMACEUTICAL INC. On March 13, 2026, Mueller disposed of 9,945 shares of Common Stock at $58.51 per share, leaving him with 106,691 shares. On March 16, 2026, he acquired 18,740 shares of Common Stock under a restricted stock unit grant with no monetary price. Additionally, on the same date, Mueller was granted an option to buy 44,600 shares of Common Stock at a price of $57.43 per share, with vesting commencing on March 16, 2027. Post-transaction, his direct holdings amount to 125,431 shares. The filing also notes a correction to previous holdings by two shares.